Eiger BioPharmaceuticals Ownership 2024 | Who Owns Eiger BioPharmaceuticals Now?
Institutional Ownership
41.86%
Insider Ownership
11.80%
Retail Ownership
46.34%
Institutional Holders
43.00
Eiger BioPharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| JPMORGAN CHASE & CO | - | - | - | -166 | -100.00% | - | Mar 31, 2024 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -48,121 | -100.00% | - | Mar 31, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -307 | -100.00% | - | Mar 31, 2024 |
| NORTHERN TRUST CORP | - | - | - | -112,323 | -100.00% | - | Mar 31, 2024 |
| STATE STREET CORP | - | - | - | -146,781 | -100.00% | - | Mar 31, 2024 |
| VANGUARD GROUP INC | - | - | - | -1,820,767 | -100.00% | - | Mar 31, 2024 |
| AMERIPRISE FINANCIAL INC | - | - | - | -7,505,539 | -100.00% | - | Mar 31, 2024 |
| CITIGROUP INC | - | - | - | -2,944 | -100.00% | - | Mar 31, 2024 |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | - | - | - | -37,325 | -100.00% | - | Mar 31, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | - | - | - | -33,436 | -100.00% | - | Mar 31, 2024 |
| MORGAN STANLEY | - | - | - | -13,812 | -100.00% | - | Mar 31, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | - | - | - | -174,088 | -100.00% | - | Mar 31, 2024 |
| NATIONAL BANK OF CANADA /FI/ | - | - | - | -1,280 | -100.00% | - | Mar 31, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -344,210 | -100.00% | - | Mar 31, 2024 |
| RHUMBLINE ADVISERS | - | - | - | -2,320 | -100.00% | - | Mar 31, 2024 |
| RBF CAPITAL, LLC | - | - | - | -338,733 | -100.00% | - | Mar 31, 2024 |
| PRUDENTIAL FINANCIAL INC | - | - | - | -12,000 | -100.00% | - | Mar 31, 2024 |
| BNP PARIBAS ARBITRAGE, SNC | - | - | - | -2,904 | -100.00% | - | Mar 31, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -379,707 | -100.00% | - | Mar 31, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -81,144 | -100.00% | - | Mar 31, 2024 |
Eiger BioPharmaceuticals's largest institutional shareholder is JPMORGAN CHASE & CO, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| JPMORGAN CHASE & CO | - | - | - | -166 | -100.00% | - | Mar 31, 2024 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -48,121 | -100.00% | - | Mar 31, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -307 | -100.00% | - | Mar 31, 2024 |
| NORTHERN TRUST CORP | - | - | - | -112,323 | -100.00% | - | Mar 31, 2024 |
| STATE STREET CORP | - | - | - | -146,781 | -100.00% | - | Mar 31, 2024 |
| VANGUARD GROUP INC | - | - | - | -1,820,767 | -100.00% | - | Mar 31, 2024 |
| AMERIPRISE FINANCIAL INC | - | - | - | -7,505,539 | -100.00% | - | Mar 31, 2024 |
| CITIGROUP INC | - | - | - | -2,944 | -100.00% | - | Mar 31, 2024 |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | - | - | - | -37,325 | -100.00% | - | Mar 31, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | - | - | - | -33,436 | -100.00% | - | Mar 31, 2024 |
| MORGAN STANLEY | - | - | - | -13,812 | -100.00% | - | Mar 31, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | - | - | - | -174,088 | -100.00% | - | Mar 31, 2024 |
| NATIONAL BANK OF CANADA /FI/ | - | - | - | -1,280 | -100.00% | - | Mar 31, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -344,210 | -100.00% | - | Mar 31, 2024 |
| RHUMBLINE ADVISERS | - | - | - | -2,320 | -100.00% | - | Mar 31, 2024 |
| RBF CAPITAL, LLC | - | - | - | -338,733 | -100.00% | - | Mar 31, 2024 |
| PRUDENTIAL FINANCIAL INC | - | - | - | -12,000 | -100.00% | - | Mar 31, 2024 |
| BNP PARIBAS ARBITRAGE, SNC | - | - | - | -2,904 | -100.00% | - | Mar 31, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -379,707 | -100.00% | - | Mar 31, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -81,144 | -100.00% | - | Mar 31, 2024 |
The largest Eiger BioPharmaceuticals shareholder by % of total assets is JPMORGAN CHASE & CO. The company owns 0.00 shares of Eiger BioPharmaceuticals (EIGR), representing 0.00% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| JPMORGAN CHASE & CO | - | - | - | -166 | -100.00% | - | Mar 31, 2024 |
| CITADEL ADVISORS LLC | - | - | - | -200 | -100.00% | - | Mar 31, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -307 | -100.00% | - | Mar 31, 2024 |
| SOUND INCOME STRATEGIES, LLC | - | - | - | -400 | -100.00% | - | Mar 31, 2024 |
| NATIONAL BANK OF CANADA /FI/ | - | - | - | -1,280 | -100.00% | - | Mar 31, 2024 |
| RHUMBLINE ADVISERS | - | - | - | -2,320 | -100.00% | - | Mar 31, 2024 |
| BNP PARIBAS ARBITRAGE, SNC | - | - | - | -2,904 | -100.00% | - | Mar 31, 2024 |
| CITIGROUP INC | - | - | - | -2,944 | -100.00% | - | Mar 31, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | - | - | - | -7,750 | -100.00% | - | Mar 31, 2024 |
| UBS GROUP AG | - | - | - | -11,045 | -100.00% | - | Mar 31, 2024 |
| PRUDENTIAL FINANCIAL INC | - | - | - | -12,000 | -100.00% | - | Mar 31, 2024 |
| SIMPLEX TRADING, LLC | - | - | - | -13,095 | -100.00% | - | Mar 31, 2024 |
| MORGAN STANLEY | - | - | - | -13,812 | -100.00% | - | Mar 31, 2024 |
| ENGINEERS GATE MANAGER LP | - | - | - | -14,478 | -100.00% | - | Mar 31, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -18,278 | -100.00% | - | Mar 31, 2024 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -20,640 | -100.00% | - | Mar 31, 2024 |
| HRT FINANCIAL LP | - | - | - | -29,118 | -100.00% | - | Mar 31, 2024 |
| JANE STREET GROUP, LLC | - | - | - | -29,505 | -100.00% | - | Mar 31, 2024 |
| TOWNSQUARE CAPITAL LLC | - | - | - | -32,430 | -100.00% | - | Mar 31, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | - | - | - | -33,436 | -100.00% | - | Mar 31, 2024 |
As of Mar 31 2024, Eiger BioPharmaceuticals's largest institutional buyer is JPMORGAN CHASE & CO. The company purchased -0.17K stocks of EIGR, valued at -.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| AMERIPRISE FINANCIAL INC | - | - | - | -7,505,539 | -100.00% | - | Mar 31, 2024 |
| PROPEL BIO MANAGEMENT, LLC | - | - | - | -4,391,432 | -100.00% | - | Mar 31, 2024 |
| 683 CAPITAL MANAGEMENT, LLC | - | - | - | -2,100,000 | -100.00% | - | Mar 31, 2024 |
| VANGUARD GROUP INC | - | - | - | -1,820,767 | -100.00% | - | Mar 31, 2024 |
| BLACKROCK INC. | - | - | - | -583,730 | -100.00% | - | Mar 31, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -379,707 | -100.00% | - | Mar 31, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -344,210 | -100.00% | - | Mar 31, 2024 |
| RBF CAPITAL, LLC | - | - | - | -338,733 | -100.00% | - | Mar 31, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | - | - | - | -174,088 | -100.00% | - | Mar 31, 2024 |
| STATE STREET CORP | - | - | - | -146,781 | -100.00% | - | Mar 31, 2024 |
| NORTHERN TRUST CORP | - | - | - | -112,323 | -100.00% | - | Mar 31, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -81,144 | -100.00% | - | Mar 31, 2024 |
| SEQUOIA FINANCIAL ADVISORS, LLC | - | - | - | -63,000 | -100.00% | - | Mar 31, 2024 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -57,221 | -100.00% | - | Mar 31, 2024 |
| VERITION FUND MANAGEMENT LLC | - | - | - | -54,182 | -100.00% | - | Mar 31, 2024 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -48,121 | -100.00% | - | Mar 31, 2024 |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | - | - | - | -37,325 | -100.00% | - | Mar 31, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | - | - | - | -33,436 | -100.00% | - | Mar 31, 2024 |
| TOWNSQUARE CAPITAL LLC | - | - | - | -32,430 | -100.00% | - | Mar 31, 2024 |
| JANE STREET GROUP, LLC | - | - | - | -29,505 | -100.00% | - | Mar 31, 2024 |
As of Mar 31 2024, Eiger BioPharmaceuticals's biggest institutional seller is AMERIPRISE FINANCIAL INC. The company sold -7.51M shares of EIGR, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| AMERIPRISE FINANCIAL INC | - | - | - | -7,505,539 | -100.00% | - | Mar 31, 2024 |
| PROPEL BIO MANAGEMENT, LLC | - | - | - | -4,391,432 | -100.00% | - | Mar 31, 2024 |
| 683 CAPITAL MANAGEMENT, LLC | - | - | - | -2,100,000 | -100.00% | - | Mar 31, 2024 |
| VANGUARD GROUP INC | - | - | - | -1,820,767 | -100.00% | - | Mar 31, 2024 |
| BLACKROCK INC. | - | - | - | -583,730 | -100.00% | - | Mar 31, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -379,707 | -100.00% | - | Mar 31, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -344,210 | -100.00% | - | Mar 31, 2024 |
| RBF CAPITAL, LLC | - | - | - | -338,733 | -100.00% | - | Mar 31, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | - | - | - | -174,088 | -100.00% | - | Mar 31, 2024 |
| STATE STREET CORP | - | - | - | -146,781 | -100.00% | - | Mar 31, 2024 |
| NORTHERN TRUST CORP | - | - | - | -112,323 | -100.00% | - | Mar 31, 2024 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -81,144 | -100.00% | - | Mar 31, 2024 |
| SEQUOIA FINANCIAL ADVISORS, LLC | - | - | - | -63,000 | -100.00% | - | Mar 31, 2024 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -57,221 | -100.00% | - | Mar 31, 2024 |
| VERITION FUND MANAGEMENT LLC | - | - | - | -54,182 | -100.00% | - | Mar 31, 2024 |
| BANK OF AMERICA CORP /DE/ | - | - | - | -48,121 | -100.00% | - | Mar 31, 2024 |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | - | - | - | -37,325 | -100.00% | - | Mar 31, 2024 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | - | - | - | -33,436 | -100.00% | - | Mar 31, 2024 |
| TOWNSQUARE CAPITAL LLC | - | - | - | -32,430 | -100.00% | - | Mar 31, 2024 |
| JANE STREET GROUP, LLC | - | - | - | -29,505 | -100.00% | - | Mar 31, 2024 |
| HRT FINANCIAL LP | - | - | - | -29,118 | -100.00% | - | Mar 31, 2024 |
| BANK OF NEW YORK MELLON CORP | - | - | - | -20,640 | -100.00% | - | Mar 31, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -18,278 | -100.00% | - | Mar 31, 2024 |
| ENGINEERS GATE MANAGER LP | - | - | - | -14,478 | -100.00% | - | Mar 31, 2024 |
| MORGAN STANLEY | - | - | - | -13,812 | -100.00% | - | Mar 31, 2024 |
| SIMPLEX TRADING, LLC | - | - | - | -13,095 | -100.00% | - | Mar 31, 2024 |
| PRUDENTIAL FINANCIAL INC | - | - | - | -12,000 | -100.00% | - | Mar 31, 2024 |
| UBS GROUP AG | - | - | - | -11,045 | -100.00% | - | Mar 31, 2024 |
| ADVISOR GROUP HOLDINGS, INC. | - | - | - | -7,750 | -100.00% | - | Mar 31, 2024 |
| CITIGROUP INC | - | - | - | -2,944 | -100.00% | - | Mar 31, 2024 |
| BNP PARIBAS ARBITRAGE, SNC | - | - | - | -2,904 | -100.00% | - | Mar 31, 2024 |
| RHUMBLINE ADVISERS | - | - | - | -2,320 | -100.00% | - | Mar 31, 2024 |
| NATIONAL BANK OF CANADA /FI/ | - | - | - | -1,280 | -100.00% | - | Mar 31, 2024 |
| SOUND INCOME STRATEGIES, LLC | - | - | - | -400 | -100.00% | - | Mar 31, 2024 |
| WELLS FARGO & COMPANY/MN | - | - | - | -307 | -100.00% | - | Mar 31, 2024 |
| CITADEL ADVISORS LLC | - | - | - | -200 | -100.00% | - | Mar 31, 2024 |
| JPMORGAN CHASE & CO | - | - | - | -166 | -100.00% | - | Mar 31, 2024 |
Eiger BioPharmaceuticals's largest sold out institutional shareholder by shares sold is AMERIPRISE FINANCIAL INC, sold -7.51M shares, valued at -, as of undefined.
Eiger BioPharmaceuticals Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| Columbia Seligman Premium Technology Growth Fund, Inc. | 0.58% | 110,761 | - | - | Mar 31, 2024 |
| Simplify Exchange Traded Funds | 0.05% | 2,700,000 | - | - | Mar 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.04% | 102,800 | - | - | Mar 28, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.04% | 19,995 | - | - | Mar 31, 2024 |
| Columbia Seligman Premium Technology Growth Fund, Inc. | 0.02% | 3,692 | 3,692 | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 63,298 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 5,951 | - | - | Mar 31, 2024 |
| Weiss Strategic Interval Fund | 0.01% | 21,332 | 21,332 | - | Sep 30, 2022 |
| Columbia Funds Series Trust II | 0.01% | 2,319,150 | - | - | Jan 31, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 2,325,913 | - | - | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 933 | - | - | Mar 31, 2024 |
| ALPS ETF Trust | 0.00% | 40,833 | - | - | Feb 29, 2024 |
| Fidelity Commonwealth Trust II | 0.00% | 15,410 | - | - | Aug 31, 2023 |
| Columbia Funds Variable Series Trust II | 0.00% | 70,340 | - | - | Mar 31, 2024 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.00% | 100,909 | - | - | Mar 31, 2024 |
| Simplify Exchange Traded Funds | 0.00% | 90,000 | 90,000 | - | Mar 28, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 349,483 | - | - | Feb 29, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 3,108 | - | - | Mar 31, 2024 |
| PRUDENTIAL INVESTMENT PORTFOLIOS, INC. | 0.00% | 8,300 | - | - | Mar 28, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 25,269 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 33,436 | - | - | Feb 29, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 8,579 | - | - | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 20,985 | - | - | Mar 31, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 2,659 | - | - | Mar 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 227 | - | - | Apr 30, 2021 |
| MFS VARIABLE INSURANCE TRUST III | 0.00% | 6,881 | - | - | Mar 31, 2024 |
| North Square Investments Trust | 0.00% | 3,197 | - | - | Jan 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 21,575 | - | - | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 1,294 | - | - | Mar 31, 2024 |
| Series Portfolios Trust | 0.00% | 1,554 | - | - | Jan 31, 2024 |
| SA FUNDS INVESTMENT TRUST | 0.00% | 4,040 | - | - | Mar 31, 2024 |
| SEASONS SERIES TRUST | 0.00% | 5,905 | - | - | Mar 31, 2024 |
| Columbia Funds Series Trust II | 0.00% | 77,304 | 77,304 | - | Feb 29, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 1,966 | - | - | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 426 | - | - | Mar 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 150,034 | - | - | Jan 31, 2024 |
| NORTHERN FUNDS | 0.00% | 19,806 | - | - | Mar 28, 2024 |
| PACE SELECT ADVISORS TRUST | 0.00% | 41,048 | - | - | Jan 31, 2024 |
| COLUMBIA FUNDS VARIABLE INSURANCE TRUST | 0.00% | 63,898 | - | - | Mar 31, 2024 |
| Dimensional ETF Trust | 0.00% | 46,933 | - | - | Jan 31, 2024 |
| Virtus Strategy Trust | 0.00% | 2,150 | - | - | Mar 28, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 6,172 | - | - | Feb 29, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 366,410 | - | - | Mar 31, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 379 | - | - | Dec 31, 2023 |
| Columbia Funds Variable Series Trust II | 0.00% | 2,344 | 2,344 | - | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 1,628 | - | - | Feb 29, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 142,135 | - | - | Feb 29, 2024 |
| VANGUARD WELLINGTON FUND | 0.00% | 25,260 | - | - | Feb 29, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 1,700 | - | - | Mar 28, 2024 |
| JPMorgan Trust I | 0.00% | 69,890 | - | - | Jan 31, 2024 |
| FLEXSHARES TRUST | 0.00% | 4,263 | - | - | Jan 31, 2024 |
| VALIC Co I | 0.00% | 15,342 | - | - | Feb 29, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 186 | - | - | Dec 31, 2023 |
| ProFunds | 0.00% | 528 | - | - | Mar 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 5,797 | - | - | Mar 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 5,084 | - | - | Jan 31, 2024 |
| PGIM ETF TRUST | 0.00% | 2,318 | - | - | Feb 29, 2024 |
| COLUMBIA FUNDS SERIES TRUST I | 0.00% | 154,186 | - | - | Feb 29, 2024 |
| Guggenheim Active Allocation Fund | 0.00% | 190 | - | - | Feb 29, 2024 |
| ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 1,660 | - | - | Dec 31, 2023 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 2,450 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 1,114 | 1,114 | - | Jan 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 76,393 | - | - | Mar 31, 2024 |
| ADVANCED SERIES TRUST | 0.00% | 76,600 | - | - | Mar 28, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 2,599 | - | - | Feb 29, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 24,351 | - | - | Mar 31, 2024 |
| VANGUARD QUANTITATIVE FUNDS | 0.00% | 100 | - | - | Mar 31, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 24 | - | - | Dec 31, 2023 |
| HC CAPITAL TRUST | 0.00% | 657 | - | - | Mar 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 4,284 | - | - | Jan 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 36,100 | - | - | Mar 31, 2024 |
| Brighthouse Funds Trust II | 0.00% | 12,775 | - | - | Mar 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 1,397 | - | - | Feb 29, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 4,776 | - | - | Mar 31, 2024 |
| PROSHARES TRUST | 0.00% | 2,826 | - | - | Feb 29, 2024 |
| ETF Series Solutions | 0.00% | 194 | - | - | Jan 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 7,180 | - | - | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 94,645 | - | - | Mar 31, 2024 |
| SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 14,962 | - | - | Dec 31, 2023 |
| WILSHIRE MUTUAL FUNDS INC | 0.00% | 1,272 | - | - | Dec 31, 2023 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 2,645 | - | - | Dec 31, 2023 |
| MFS SERIES TRUST X | 0.00% | 24,441 | - | - | Jan 31, 2024 |
| GOLDMAN SACHS TRUST | 0.00% | 8,746 | - | - | Mar 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 747 | - | - | Jan 31, 2024 |
| Bridge Builder Trust | 0.00% | 6,925 | - | - | Mar 31, 2024 |
| Meeder Funds | 0.00% | 7 | - | - | Mar 31, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 5,579 | - | - | Mar 31, 2024 |
| BLACKROCK FUNDS | 0.00% | 7,696 | - | - | Mar 28, 2024 |
| PACIFIC SELECT FUND | 0.00% | 3,087 | - | - | Mar 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 4,930 | - | - | Feb 29, 2024 |
| Advisors' Inner Circle Fund III | 0.00% | 40 | - | - | Jan 31, 2024 |
| John Hancock Funds II | 0.00% | 4,379 | - | - | Feb 29, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 622 | - | - | Mar 31, 2024 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 5,600 | - | - | Feb 29, 2024 |
Eiger BioPharmaceuticals's largest mutual fund holder by % of total assets is "Columbia Seligman Premium Technology Growth Fund, Inc.", owning 110.76K shares, compromising 0.58% of its total assets.
Eiger BioPharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 31 Dec, 23 | 43 | -10.42% |
| 30 Sep, 23 | 48 | -25.00% |
| 30 Jun, 23 | 64 | -9.86% |
| 31 Mar, 23 | 71 | -16.47% |
| 31 Dec, 22 | 85 | -13.27% |
| 30 Sep, 22 | 98 | 5.38% |
| 30 Jun, 22 | 93 | -8.82% |
| 31 Mar, 22 | 102 | 21.43% |
| 31 Dec, 21 | 84 | -8.70% |
| 30 Sep, 21 | 92 | -1.08% |
| 30 Jun, 21 | 93 | -4.12% |
| 31 Mar, 21 | 97 | 3.19% |
| 31 Dec, 20 | 94 | -11.32% |
| 30 Sep, 20 | 106 | 15.22% |
| 30 Jun, 20 | 92 | - |
| 31 Mar, 20 | 92 | - |
| 31 Dec, 19 | 92 | 10.84% |
| 30 Sep, 19 | 83 | 6.41% |
| 30 Jun, 19 | 78 | 23.81% |
| 31 Mar, 19 | 63 | -8.70% |
| 31 Dec, 18 | 69 | 32.69% |
| 30 Sep, 18 | 52 | 6.12% |
| 30 Jun, 18 | 49 | 28.95% |
| 31 Mar, 18 | 38 | -2.56% |
| 31 Dec, 17 | 39 | 25.81% |
| 30 Sep, 17 | 31 | -18.42% |
| 30 Jun, 17 | 38 | -19.15% |
| 31 Mar, 17 | 47 | -6.00% |
| 31 Dec, 16 | 50 | 8.70% |
| 30 Sep, 16 | 46 | - |
| 30 Jun, 16 | 46 | 48.39% |
| 31 Mar, 16 | 31 | - |
As of 31 Dec 23, 43 institutions are holding Eiger BioPharmaceuticals's shares, representing a decrease of -10.42% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 31 Dec, 23 | 18,552,710 | -6.97% |
| 30 Sep, 23 | 19,942,909 | -4.07% |
| 30 Jun, 23 | 20,788,715 | -16.17% |
| 31 Mar, 23 | 24,797,793 | -3.03% |
| 31 Dec, 22 | 25,572,536 | -16.00% |
| 30 Sep, 22 | 30,444,991 | 2.14% |
| 30 Jun, 22 | 29,805,961 | -2.33% |
| 31 Mar, 22 | 30,517,219 | 27.58% |
| 31 Dec, 21 | 23,919,604 | 5.88% |
| 30 Sep, 21 | 22,591,615 | -1.96% |
| 30 Jun, 21 | 23,042,162 | -1.73% |
| 31 Mar, 21 | 23,446,753 | -0.43% |
| 31 Dec, 20 | 23,546,856 | 5.44% |
| 30 Sep, 20 | 22,331,055 | 14.70% |
| 30 Jun, 20 | 19,468,677 | 8.69% |
| 31 Mar, 20 | 17,911,362 | -2.93% |
| 31 Dec, 19 | 18,451,520 | -1.18% |
| 30 Sep, 19 | 18,671,135 | -9.84% |
| 30 Jun, 19 | 20,708,899 | 34.35% |
| 31 Mar, 19 | 15,414,383 | -1.01% |
| 31 Dec, 18 | 15,572,252 | 58.61% |
| 30 Sep, 18 | 9,817,984 | -0.48% |
| 30 Jun, 18 | 9,865,430 | 41.85% |
| 31 Mar, 18 | 6,954,675 | -4.14% |
| 31 Dec, 17 | 7,254,866 | 46.67% |
| 30 Sep, 17 | 4,946,224 | -1.29% |
| 30 Jun, 17 | 5,011,035 | -13.38% |
| 31 Mar, 17 | 5,785,264 | -4.27% |
| 31 Dec, 16 | 6,043,015 | 33.66% |
| 30 Sep, 16 | 4,521,078 | 39.41% |
| 30 Jun, 16 | 3,243,042 | 6.40% |
| 31 Mar, 16 | 3,047,833 | - |
Eiger BioPharmaceuticals (EIGR) has 18.55M shares outstanding as of 31 Dec 23, down -6.97% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 31 Dec, 23 | 41.86% | 2.07% |
| 30 Sep, 23 | 45.02% | 2.03% |
| 30 Jun, 23 | 47.09% | 1.49% |
| 31 Mar, 23 | 56.17% | 1.67% |
| 31 Dec, 22 | 58.03% | 1.21% |
| 30 Sep, 22 | 69.18% | 1.44% |
| 30 Jun, 22 | 69.22% | 0.92% |
| 31 Mar, 22 | 86.57% | 1.75% |
| 31 Dec, 21 | 70.33% | 1.59% |
| 30 Sep, 21 | 66.55% | 1.44% |
| 30 Jun, 21 | 67.91% | 1.42% |
| 31 Mar, 21 | 69.19% | 1.11% |
| 31 Dec, 20 | 78.81% | 1.41% |
| 30 Sep, 20 | 74.74% | 1.28% |
| 30 Jun, 20 | 76.34% | 1.43% |
| 31 Mar, 20 | 73.10% | 1.11% |
| 31 Dec, 19 | 80.98% | 1.39% |
| 30 Sep, 19 | 76.40% | 0.98% |
| 30 Jun, 19 | 88.47% | 1.37% |
| 31 Mar, 19 | 80.42% | 1.07% |
| 31 Dec, 18 | 86.87% | 1.83% |
| 30 Sep, 18 | 68.87% | 1.03% |
| 30 Jun, 18 | 81.90% | 1.88% |
| 31 Mar, 18 | 66.05% | 0.96% |
| 31 Dec, 17 | 83.12% | 2.38% |
| 30 Sep, 17 | 59.07% | 1.65% |
| 30 Jun, 17 | 59.89% | 1.25% |
| 31 Mar, 17 | 69.20% | 0.68% |
| 31 Dec, 16 | 100.60% | 2.86% |
| 30 Sep, 16 | 59.31% | 2.82% |
| 30 Jun, 16 | 45.88% | 2.47% |
| 31 Mar, 16 | 43.11% | - |
As of 31 Dec 23, Eiger BioPharmaceuticals is held by 41.86% institutional shareholders, representing a 2.07% growth compared to 30 Sep 23.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 31 Dec, 23 | 11 | -8.33% |
| 30 Sep, 23 | 12 | -52.00% |
| 30 Jun, 23 | 25 | -19.35% |
| 31 Mar, 23 | 31 | -35.42% |
| 31 Dec, 22 | 48 | -5.88% |
| 30 Sep, 22 | 51 | 13.33% |
| 30 Jun, 22 | 45 | -16.67% |
| 31 Mar, 22 | 54 | 20.00% |
| 31 Dec, 21 | 45 | 7.14% |
| 30 Sep, 21 | 42 | -4.55% |
| 30 Jun, 21 | 44 | 37.50% |
| 31 Mar, 21 | 32 | -42.86% |
| 31 Dec, 20 | 56 | -5.08% |
| 30 Sep, 20 | 59 | -7.81% |
| 30 Jun, 20 | 64 | 12.28% |
| 31 Mar, 20 | 57 | 14.00% |
| 31 Dec, 19 | 50 | 13.64% |
| 30 Sep, 19 | 44 | -13.73% |
| 30 Jun, 19 | 51 | 82.14% |
| 31 Mar, 19 | 28 | -44.00% |
| 31 Dec, 18 | 50 | 78.57% |
| 30 Sep, 18 | 28 | -6.67% |
| 30 Jun, 18 | 30 | 25.00% |
| 31 Mar, 18 | 24 | 14.29% |
| 31 Dec, 17 | 21 | 50.00% |
| 30 Sep, 17 | 14 | -33.33% |
| 30 Jun, 17 | 21 | 23.53% |
| 31 Mar, 17 | 17 | -29.17% |
| 31 Dec, 16 | 24 | -27.27% |
| 30 Sep, 16 | 33 | 13.79% |
| 30 Jun, 16 | 29 | -6.45% |
| 31 Mar, 16 | 31 | - |
11 institutional shareholders have increased their position in EIGR stock as of 31 Dec 23 compared to 12 in the previous quarter (a -8.33% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 31 Dec, 23 | 16 | -20.00% |
| 30 Sep, 23 | 20 | -28.57% |
| 30 Jun, 23 | 28 | 16.67% |
| 31 Mar, 23 | 24 | - |
| 31 Dec, 22 | 24 | - |
| 30 Sep, 22 | 24 | -11.11% |
| 30 Jun, 22 | 27 | -12.90% |
| 31 Mar, 22 | 31 | 55.00% |
| 31 Dec, 21 | 20 | 5.26% |
| 30 Sep, 21 | 19 | -29.63% |
| 30 Jun, 21 | 27 | -22.86% |
| 31 Mar, 21 | 35 | 84.21% |
| 31 Dec, 20 | 19 | -26.92% |
| 30 Sep, 20 | 26 | 52.94% |
| 30 Jun, 20 | 17 | -22.73% |
| 31 Mar, 20 | 22 | -4.35% |
| 31 Dec, 19 | 23 | 15.00% |
| 30 Sep, 19 | 20 | 33.33% |
| 30 Jun, 19 | 15 | -16.67% |
| 31 Mar, 19 | 18 | 80.00% |
| 31 Dec, 18 | 10 | - |
| 30 Sep, 18 | 10 | 11.11% |
| 30 Jun, 18 | 9 | 80.00% |
| 31 Mar, 18 | 5 | -50.00% |
| 31 Dec, 17 | 10 | 66.67% |
| 30 Sep, 17 | 6 | -14.29% |
| 30 Jun, 17 | 7 | -36.36% |
| 31 Mar, 17 | 11 | - |
| 31 Dec, 16 | 11 | 175.00% |
| 30 Sep, 16 | 4 | -33.33% |
| 30 Jun, 16 | 6 | - |
| 31 Mar, 16 | - | - |
16 institutional shareholders have reduced their position in EIGR stock as of 31 Dec 23 compared to 20 in the previous quarter (a -20.00% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Dec, 23 | 43 | -10.42% | 18,552,710 | -6.97% | 41.86% | 2.07% | 11 | -8.33% | 16 | -20.00% |
| 30 Sep, 23 | 48 | -25.00% | 19,942,909 | -4.07% | 45.02% | 2.03% | 12 | -52.00% | 20 | -28.57% |
| 30 Jun, 23 | 64 | -9.86% | 20,788,715 | -16.17% | 47.09% | 1.49% | 25 | -19.35% | 28 | 16.67% |
| 31 Mar, 23 | 71 | -16.47% | 24,797,793 | -3.03% | 56.17% | 1.67% | 31 | -35.42% | 24 | - |
| 31 Dec, 22 | 85 | -13.27% | 25,572,536 | -16.00% | 58.03% | 1.21% | 48 | -5.88% | 24 | - |
| 30 Sep, 22 | 98 | 5.38% | 30,444,991 | 2.14% | 69.18% | 1.44% | 51 | 13.33% | 24 | -11.11% |
| 30 Jun, 22 | 93 | -8.82% | 29,805,961 | -2.33% | 69.22% | 0.92% | 45 | -16.67% | 27 | -12.90% |
| 31 Mar, 22 | 102 | 21.43% | 30,517,219 | 27.58% | 86.57% | 1.75% | 54 | 20.00% | 31 | 55.00% |
| 31 Dec, 21 | 84 | -8.70% | 23,919,604 | 5.88% | 70.33% | 1.59% | 45 | 7.14% | 20 | 5.26% |
| 30 Sep, 21 | 92 | -1.08% | 22,591,615 | -1.96% | 66.55% | 1.44% | 42 | -4.55% | 19 | -29.63% |
| 30 Jun, 21 | 93 | -4.12% | 23,042,162 | -1.73% | 67.91% | 1.42% | 44 | 37.50% | 27 | -22.86% |
| 31 Mar, 21 | 97 | 3.19% | 23,446,753 | -0.43% | 69.19% | 1.11% | 32 | -42.86% | 35 | 84.21% |
| 31 Dec, 20 | 94 | -11.32% | 23,546,856 | 5.44% | 78.81% | 1.41% | 56 | -5.08% | 19 | -26.92% |
| 30 Sep, 20 | 106 | 15.22% | 22,331,055 | 14.70% | 74.74% | 1.28% | 59 | -7.81% | 26 | 52.94% |
| 30 Jun, 20 | 92 | - | 19,468,677 | 8.69% | 76.34% | 1.43% | 64 | 12.28% | 17 | -22.73% |
| 31 Mar, 20 | 92 | - | 17,911,362 | -2.93% | 73.10% | 1.11% | 57 | 14.00% | 22 | -4.35% |
| 31 Dec, 19 | 92 | 10.84% | 18,451,520 | -1.18% | 80.98% | 1.39% | 50 | 13.64% | 23 | 15.00% |
| 30 Sep, 19 | 83 | 6.41% | 18,671,135 | -9.84% | 76.40% | 0.98% | 44 | -13.73% | 20 | 33.33% |
| 30 Jun, 19 | 78 | 23.81% | 20,708,899 | 34.35% | 88.47% | 1.37% | 51 | 82.14% | 15 | -16.67% |
| 31 Mar, 19 | 63 | -8.70% | 15,414,383 | -1.01% | 80.42% | 1.07% | 28 | -44.00% | 18 | 80.00% |
| 31 Dec, 18 | 69 | 32.69% | 15,572,252 | 58.61% | 86.87% | 1.83% | 50 | 78.57% | 10 | - |
| 30 Sep, 18 | 52 | 6.12% | 9,817,984 | -0.48% | 68.87% | 1.03% | 28 | -6.67% | 10 | 11.11% |
| 30 Jun, 18 | 49 | 28.95% | 9,865,430 | 41.85% | 81.90% | 1.88% | 30 | 25.00% | 9 | 80.00% |
| 31 Mar, 18 | 38 | -2.56% | 6,954,675 | -4.14% | 66.05% | 0.96% | 24 | 14.29% | 5 | -50.00% |
| 31 Dec, 17 | 39 | 25.81% | 7,254,866 | 46.67% | 83.12% | 2.38% | 21 | 50.00% | 10 | 66.67% |
| 30 Sep, 17 | 31 | -18.42% | 4,946,224 | -1.29% | 59.07% | 1.65% | 14 | -33.33% | 6 | -14.29% |
| 30 Jun, 17 | 38 | -19.15% | 5,011,035 | -13.38% | 59.89% | 1.25% | 21 | 23.53% | 7 | -36.36% |
| 31 Mar, 17 | 47 | -6.00% | 5,785,264 | -4.27% | 69.20% | 0.68% | 17 | -29.17% | 11 | - |
| 31 Dec, 16 | 50 | 8.70% | 6,043,015 | 33.66% | 100.60% | 2.86% | 24 | -27.27% | 11 | 175.00% |
| 30 Sep, 16 | 46 | - | 4,521,078 | 39.41% | 59.31% | 2.82% | 33 | 13.79% | 4 | -33.33% |
| 30 Jun, 16 | 46 | 48.39% | 3,243,042 | 6.40% | 45.88% | 2.47% | 29 | -6.45% | 6 | - |
| 31 Mar, 16 | 31 | - | 3,047,833 | - | 43.11% | - | 31 | - | - | - |
Eiger BioPharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of Eiger BioPharmaceuticals's stock was made by Choong Ingrid on Sep 05 2023, selling - shares at - per share (valued at -). The last insider buy of EIGR was made by KAYNE RICHARD A on Nov 02 2023, buying 23,398 shares at $0.30 per share (worth $6.97K).
Eiger BioPharmaceuticals Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q4 2023 | 7 | - | - |
| Q3 2023 | 2 | 12 | 16.67% |
| Q2 2023 | 1 | - | - |
| Q1 2023 | 12 | 2 | 600.00% |
| Q4 2022 | 1 | 2 | 50.00% |
| Q3 2022 | 1 | 1 | 100.00% |
| Q1 2022 | 11 | 3 | 366.67% |
| Q3 2021 | 4 | - | - |
| Q2 2021 | 4 | - | - |
| Q1 2021 | 22 | 2 | 1100.00% |
| Q3 2020 | 3 | - | - |
| Q1 2020 | 26 | - | - |
| Q3 2019 | 3 | - | - |
| Q2 2019 | 5 | - | - |
| Q1 2019 | 15 | 1 | 1500.00% |
| Q4 2018 | 5 | 2 | 250.00% |
| Q3 2018 | 2 | - | - |
| Q2 2018 | 1 | 2 | 50.00% |
| Q1 2018 | 13 | - | - |
| Q3 2017 | 5 | - | - |
7 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Eiger BioPharmaceuticals's insiders, as of Q4 2023.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q4 2023 | 7 | - | - |
| Q3 2023 | - | - | - |
| Q2 2023 | - | - | - |
| Q1 2023 | 1 | 2 | 50.00% |
| Q4 2022 | 1 | 2 | 50.00% |
| Q3 2022 | - | 1 | - |
| Q1 2022 | - | 3 | - |
| Q3 2021 | - | - | - |
| Q2 2021 | 2 | - | - |
| Q1 2021 | - | 2 | - |
| Q3 2020 | 3 | - | - |
| Q1 2020 | 4 | - | - |
| Q3 2019 | - | - | - |
| Q2 2019 | 4 | - | - |
| Q1 2019 | 2 | - | - |
| Q4 2018 | 5 | 2 | 250.00% |
| Q3 2018 | - | - | - |
| Q2 2018 | - | 1 | - |
| Q1 2018 | - | - | - |
| Q3 2017 | 1 | - | - |
As of Q4 2023, Insider owners conducted 7 open market buy trades and 0 open market sell trades of Eiger BioPharmaceuticals's stocks.
Eiger BioPharmaceuticals Peer Ownership
| Ticker | Company |
|---|---|
| GRCL | Gracell Biotechnologies Inc. |
| NUVB | Nuvation Bio Inc. |
| XFOR | X4 Pharmaceuticals, Inc. |
| FUSN | Fusion Pharmaceuticals Inc. |
| APLT | Applied Therapeutics, Inc. |
| DAWN | Day One Biopharmaceuticals, Inc. |
| SPRB | Spruce Biosciences, Inc. |
| SPRO | Spero Therapeutics, Inc. |
| FNCH | Finch Therapeutics Group, Inc. |
| ETON | Eton Pharmaceuticals, Inc. |
| CING | Cingulate Inc. |
| TERN | Terns Pharmaceuticals, Inc. |
| CNTB | Connect Biopharma Holdings Limited |
| BOLT | Bolt Biotherapeutics, Inc. |
| INZY | Inozyme Pharma, Inc. |
| ELDN | Eledon Pharmaceuticals, Inc. |
| ABOS | Acumen Pharmaceuticals, Inc. |
| HOWL | Werewolf Therapeutics, Inc. |
| UNCY | Unicycive Therapeutics, Inc. |
| NLTX | Neurogene Inc. |
| CHRS | Coherus BioSciences, Inc. |
| LYRA | Lyra Therapeutics, Inc. |
EIGR Ownership FAQ
Who Owns Eiger BioPharmaceuticals?
Eiger BioPharmaceuticals is owned by institutional shareholders (41.86%), insiders (11.80%), and public (46.34%). The largest institutional shareholder of Eiger BioPharmaceuticals is JPMORGAN CHASE & CO (0% of total shares) and the top mutual fund owner is Columbia Seligman Premium Technology Growth Fund, Inc. (0.58% of total shares).
Who are the major institutional shareholders of Eiger BioPharmaceuticals?
Eiger BioPharmaceuticals's major institutional shareholders are JPMORGAN CHASE & CO, BANK OF AMERICA CORP /DE/, WELLS FARGO & COMPANY/MN, NORTHERN TRUST CORP, and STATE STREET CORP. The top five shareholders own together 0% of the company's share outstanding.
How many Eiger BioPharmaceuticals shareholders are there?
As of Dec 2023, there are 43 institutional shareholders of Eiger BioPharmaceuticals.
What percentage of Eiger BioPharmaceuticals is owned by JPMORGAN CHASE & CO?
JPMORGAN CHASE & CO owns 0 shares of Eiger BioPharmaceuticals, representing 0% of the company's total shares outstanding, valued at $0 (as of Mar 2024).
What percentage of Eiger BioPharmaceuticals is owned by BANK OF AMERICA CORP /DE/?
As of Mar 2024, BANK OF AMERICA CORP /DE/ holds 0 shares of Eiger BioPharmaceuticals (EIGR), compromising 0% of the company, valued at $0.
What percentage of Eiger BioPharmaceuticals is owned by WELLS FARGO & COMPANY/MN?
WELLS FARGO & COMPANY/MN is the third largest holder of Eiger BioPharmaceuticals. The company owns 0 of the company's shares outstanding (worth $0).